Banque Internationale à Luxembourg S.A. Share Price

Certificat

ATBBIL

CH1284253866

Market Closed - Swiss Exchange 08:50:00 04/06/2024 pm IST
98.34 CHF -0.54% Intraday chart for Banque Internationale à Luxembourg S.A.
Current month+0.40%
1 month+3.48%
Date Price Change
04/24/04 98.34 -0.54%
03/24/03 98.87 +0.94%
31/24/31 97.95 +0.40%
30/24/30 97.56 +0.27%
29/24/29 97.3 -0.69%

Delayed Quote Swiss Exchange

Last update June 04, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Banque Internationale à Luxembourg S.A.
ATBBIL
ISINCH1284253866
Date issued 16/01/2024
Strike 250.1 CHF
Maturity 16/01/2026 (591 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 99.57 CHF
Lowest since issue 93.06 CHF
Spread 8 CHF
Spread %0.81%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
234.2 CHF
Average target price
277.5 CHF
Spread / Average Target
+18.50%
Consensus
  1. Stock Market
  2. Certificates
  3. ATBBIL Certificat